Yazar "Castagna L." için listeleme
-
Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party (Bone Marrow Transplantation, (2023), 58, 1, (54-60), 10.1038/s41409-022-01839-8)
Santoro N.; Mooyaart J.E.; Devillier R.; Koc Y.; Vydra J.; Castagna L.; Gülbas Z. (Springer Nature, 2023)The color coding for our three subsets of patients were not identical in Figure 1 and Figure 2. While the "therapeutic" subset appears in green in both figures, the "pre-emptive" group appears in blue in Figure 1 and in ... -
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Montoro J.; Boumendil A.; Finel H.; Bramanti S.; Castagna L.; Blaise D.; Dominietto A. (Elsevier B.V., 2024)Post-transplantation cyclophosphamide (PTCy) has emerged as a promising approach for preventing graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, there is a lack ...